Last reviewed · How we verify
R2-Total targeted treatment with azithromycin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
R2-Total targeted treatment with azithromycin (R2-Total targeted treatment with azithromycin) — Lihir Medical Centre.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| R2-Total targeted treatment with azithromycin TARGET | R2-Total targeted treatment with azithromycin | Lihir Medical Centre | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- R2-Total targeted treatment with azithromycin CI watch — RSS
- R2-Total targeted treatment with azithromycin CI watch — Atom
- R2-Total targeted treatment with azithromycin CI watch — JSON
- R2-Total targeted treatment with azithromycin alone — RSS
Cite this brief
Drug Landscape (2026). R2-Total targeted treatment with azithromycin — Competitive Intelligence Brief. https://druglandscape.com/ci/r2-total-targeted-treatment-with-azithromycin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab